Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases

Br J Dermatol. 2016 Dec;175(6):1382-1386. doi: 10.1111/bjd.14642. Epub 2016 Oct 17.

Authors

L Borradori^{1

2}, B Sutton¹, P Shayesteh¹, G A Daniels¹

Affiliations

¹ Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093, U.S.A.
² Department of Dermatology, University Hospital, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.

PMID: 27059424
DOI: 10.1111/bjd.14642

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents / therapeutic use*
Carcinoma, Basosquamous / drug therapy*
Carcinoma, Squamous Cell / drug therapy*
Facial Neoplasms / drug therapy
Female
Head and Neck Neoplasms / drug therapy*
Humans
Male
Middle Aged
Nivolumab
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Salvage Therapy / methods
Scalp
Skin Neoplasms / drug therapy*
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
PDCD1 protein, human
Programmed Cell Death 1 Receptor
Nivolumab